Our study could provide an important clue to the clinical roles of CREB3L1 and PTN expressions in evaluating grade-versions of brain gliomas, and thus may offer an appropriately therapeutic option for the cancer patients. This evidence concerns the gene CREB3L1 and brain glioma.